Exploring the Mechanism of "Radix Bupleuri-Paeoniae Radix Alba" in the Treatment of Post-Stroke Depression Based on Network Pharmacology and Molecular Docking

Xia Zhou; Zhidong Zeng; Yanli Fu; Lei Chen

doi:10.62767/jecacm504.9815

Authors

Xia Zhou Department of Pharmacy, Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, 518000 Shenzhen, Guangdong, China Author
Zhidong Zeng Department of Pharmacy, Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, 518000 Shenzhen, Guangdong, China Author
Yanli Fu Department of Oncology, Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, 518000 Shenzhen, Guangdong, China Author
Lei Chen Department of Pharmacy, Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, 518000 Shenzhen, Guangdong, China Author

DOI:

https://doi.org/10.62767/jecacm504.9815

Keywords:

Radix Bupleuri-Paeoniae Radix Alba, medicine pair, post-stroke depression, network pharmacology, molecular docking

Abstract

Purpose: To explore the mechanism of "Radix Bupleuri-Paeoniae Radix Alba" in the treatment of post-stroke depression through network pharmacology and molecular docking. Methods: The active ingredients and targets of "Radix Bupleuri-Paeoniae Radix Alba" were predicted by Traditional Chinese Medicine Systems Pharmacology (TCMSP) database. The related targets of post-stroke depression were searched in GeneCards, NCBI and DisGeNET databases. Cystoscape software was used to construct the "Chinese Medicine-Active Ingredient-Disease-Intersection Target" network, followed by Gene Ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses. The active ingredients corresponding to the core targets were verified by molecular docking techniques. Results: A total of 145 potential core targets of "Radix Bupleuri-Paeoniae Radix Alba" in the treatment of post-stroke depression were identified. The core ingredients such as quercetin, kaempferol and β-sitosterol, and the key protein targets such as RAC-alpha serine/threonine-protein kinase 1 (AKT1), Interleukin-6 (IL-6) and Interleukin-1β (IL-1β) were screened out. KEGG pathway enrichment analysis mainly involved "lipids and atherosclerosis", "chemical carcinogenesis-receptor activation", and "hepatitis B". Molecular docking results showed that quercetin and kaempferol, the main active ingredients of "Radix Bupleuri-Paeoniae Radix Alba", had good affinity with the key potential targets AKT1, IL-6 and IL-1β. Conclusion: The pair of "Radix Bupleuri-Paeoniae Radix Alba" may act on the core targets such as AKT1, IL-6 and IL-1β through the main active ingredients including quercetin and kaempferol, and may effectively treat post-stroke depression by regulating multiple signaling pathways such as "lipids and atherosclerosis" and "hepatitis B".

References

Villa RF, Ferrari F, Moretti A. Post-stroke depression: Mechanisms and pharmacological treatment. Pharmacology & Therapeutics 2018; 184: 131-144.

Ayerbe L, Ayis S, Wolfe CD, et al. Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis. British Journal of Psychiatry 2013; 202(1): 14-21.

Das J, Rajanikant GK. Post stroke depression: The sequelae of cerebral stroke. Neuroscience & Biobehavioral Reviews 2018; 90: 104-114.

Vicentini JE, Weiler M, Almeida SRM, et al. Depression and anxiety symptoms are associated to disruption of default mode network in subacute ischemic stroke. Brain Imaging and Behavior 2017; 11(6): 1571-1580.

Shi Y, Yang D, Zeng Y, et al. Risk Factors for Post-stroke Depression: A Meta-analysis. Frontiers in Aging Neuroscience 2017; 9: 218.

Kootker JA, van Mierlo ML, Hendriks JC, et al. Risk Factors for Symptoms of Depression and Anxiety One Year Poststroke: A Longitudinal Study. Archives of Physical Medicine and Rehabilitation 2016; 97(6): 919-928.

Shi Y, Xiang Y, Yang Y, et al. Depression after minor stroke: Prevalence and predictors. Journal of Psychosomatic Research 2015; 79(2): 143-147.

Lin S, Luan X, He W, et al. Post-Stroke Depression and Estimated Glomerular Filtration Rate: A Prospective Stroke Cohort. Neuropsychiatric Disease and Treatment 2020; 16: 201-208.

Choi-Kwon S, Han SW, Kwon SU, et al. Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a double-blind, placebo-controlled study. Stroke 2006; 37(1): 156-161.

Price A, Rayner L, Okon-Rocha E, et al. Antidepressants for the treatment of depression in neurological disorders: a systematic review and meta-analysis of randomised controlled trials. Journal of Neurology, Neurosurgery and Psychiatry 2011; 82(8): 914-923.

Fang C, Zhang Z, Xu H, et al. Natural Products for the Treatment of Post-stroke Depression. Frontiers in Pharmacology 2022; 13: 918531.

Zhao AM, Qiu WR, Mao LJ, et al. The efficacy and safety of Jiedu Tongluo granules for treating post-stroke depression with qi deficiency and blood stasis syndrome: study protocol for a randomized controlled trial. Trials 2018; 19(1): 275.

Zhang Y, Yang Y, Feng Y, et al. The association between liver fibrosis and depression in patients after ischemic stroke. BMC Neurology 2023; 23(1): 50.

Yuan M, Yuan J, Han Z. Analysis on the medication rules of traditional Chinese medicine in treat-ing poststroke depression based on traditional Chinese medicine inheri-tance support system. China Medical Herald 2021; 18: 159-162.

Zhong Y, Li J, Zhu X, et al. A comprehensive review of bupleuri radix and its bioactive components: with a major focus on treating chronic liver diseases. Journal of Ethnopharmacology 2024; 330: 118244.

Li J, Li X, Gao Y, et al. Clinical Application and Modern Pharmacological Research Progress of Radix Bupleurum and Paeoniae Alba. Journal of Liaoning University of Traditional Chinese Medicine 2019; 21(07): 8-12.

Wang H, Zhou Q, Li B, et al. Chemical compositions and pharmacological effects of Chinese thorowax root: review. Jilin Journal of Chinese Medicine 2024; 44(01): 96-100.

Tan YQ, Chen HW, Li J, et al. Efficacy, Chemical Constituents, and Pharmacological Actions of Radix Paeoniae Rubra and Radix Paeoniae Alba. Frontiers in Pharmacology 2020; 11: 1054.

Wang Y, Gao SM, Li R, et al. Antidepressant-like effects of the Radix Bupleuri and Radix Paeoniae Alba drug pair. Neuroscience Letters 2016; 633: 14-20.

Doncheva NT, Morris JH, Gorodkin J, et al. Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data. Journal of Proteome Research 2019; 18(2): 623-632.

Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Research 2019; 47(D1): D607-D613.

Wang H, Mao S, Wang P, et al. Research advances in the pathogenesis and risk factors of post-stroke depression. Journal of Apoplexy and Nervous Diseases 2023; 40(09): 785-788.

Shi Y, Yang D, Zeng Y, et al. Risk Factors for Post-stroke Depression: A Meta-analysis. Frontiers in Aging Neuroscience 2017; 9: 218.

Du F, Fang L, Zhang C, et al. Clinical Effect of Yinao Jieyu Formula Combined with Acupuncture in the Treatment of Post Stroke Depression. Medical Innovation of China 2021; 18(09): 94-98.

Wang C, Wu C, Yan Z, et al. Ameliorative effect of Xiaoyao-jieyu-san on post-stroke depression and its potential mechanisms. Journal of Natural Medicines 2019; 73(1): 76-84.

Wang Y, Wang Y, Zou M, et al. Research progress on antidepressant effect and mechanism of quercetin and its glycoside derivatives. Chinese Herbal Medicine 2022; 53(05): 1548-1557.

Ma N, Li Y, Fan J. Research Progress on Pharmacological Action of Quercetin. Journal of Liaoning University of Traditional Chinese Medicine 2018; 20(08): 221-224.

Wang J, Xie J, Chen Y, et al. Antidepressant Effect of Kaempferol on Rat Complex Model of Depression and Breast Cancer. Chinese Journal of Modern Applied Pharmacy 2016; 33(03): 277-280.

Zhao D, Zheng L, Qi L, et al. Structural Features and Potent Antidepressant Effects of Total Sterols and β-sitosterol Extracted from Sargassum horneri. Marine Drugs 2016; 14(7): 123.

Xu Q, Qian X, Sun F, et al. Effects of crocin on inflammatory response and TLR4/MyD88/NF-κB signaling pathway in post-stroke depression rats. Chinese Journal of Immunology 2021; 37(02): 179-185.

Kim JM, Kang HJ, Kim JW, et al. Associations of Tumor Necrosis Factor-α and Interleukin-1β Levels and Polymorphisms with Post-Stroke Depression. The American Journal of Geriatric Psychiatry 2017; 25(12): 1300-1308.

Chen Y, Pu J, Liu Y, et al. Pro-infammatory cytokines are associated with the development of post-stroke depression in the acute stage of stroke: a meta-analysis. Topics in Stroke Rehabilitation 2020; 27(8): 620–629.

Yang L, Zhang Z, Sun D, et al. The serum interleukin-18 is a potential marker for development of post-stroke depression. Neurological Research 2010; 32(4): 340-346.

Song MY, Cho H, Lee S, et al. Daeshiho-tang Attenuates Atherosclerosis by Regulating Cholesterol Metabolism and Inducing M2 Macrophage Polarization. Life 2022; 12(2): 197.

Kahl KG, Krüger T, Eckermann G, et al. Depressionen und Lebererkrankungen: Die Rolle von Mikrobiom und Inflammation [Major depression and liver disease: the role of microbiome and inflammation]. Fortschritte der Neurologie Psychiatrie 2019; 87(1): 12-21.